Professional Documents
Culture Documents
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide
range of content in a trusted digital archive. We use information technology and tools to increase productivity and
facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at
https://about.jstor.org/terms
and Wiley are collaborating with JSTOR to digitize, preserve and extend access to
Hypatia
SUSAN C. C. HAWTHORNE
Current Controversies, C
DlCHOTOMIZATION, EMBEDDED
A broad range of social support encourages the study of ADHD. The range
reflects a confluence of needs: those of children to cope with school, schools to
cope with children, adults to succeed at work, government to prevent delin-
quency, medical institutions to control costs, and drug companies to make a
profit. Over the past decade, the National Institutes of Health (NIH) have
contributed an average of U.S.$107 million annually to U.S. ADHD research.8
The pharmaceutical industry also funds much research concerning ADHD
medication; the extent of this support is proprietary, but it likely dwarfs gov-
ernment expenditures (Angeli 2004). On a smaller scale, school psychologists
and other educators also receive funding to investigate ADHD management in
schools. In brief, ADHD is a social priority.
Institutionalized Intolerance
The multiply influenced, dichotomized ADHD category is now part of our so-
cial world, molding options and judgments. Norms of achievement, control,
and attention are institutionalized, as is the social pressure to conform to these
norms. The effects are not the same for all ADHD-diagnosable people, or for all
their caregivers. Overall, though, the negative valuation of ADHD traits and
behaviors, and the people who exhibit them; the social goals of managing the
traits and behaviors quickly, inexpensively, and by intervention on individuals;
and the requirements that social structures impose on ADHD-diagnosable in-
dividuals and their caregivers, together constitute institutionalized intolerance
of ADHD and of those who "have" it.
Constraints
Social Pressures
Internalizing
Alternatives?
I have argued that a confluence of needs, interests, and practices from across
the social and scientific spectrum has institutionalized intolerance of ADHD-
associated traits and behaviors, and of people who exhibit them. This has not
been the intention of the many people and institutions involved. But a positive
feedback loop has jointly reinforced the predominant biomedicai ADHD con-
cept, the social values embedded in that concept, and the institutional
Notes
Many thanks to Helen Longino, C. Kenneth Waters, Valerie Tiberius, Monica Luciana,
Carl Elliott, Patricia Ross, members of the Biological Interest Group at the University of
Minnesota, and Hypatia's anonymous reviewers for their insightful critiques of earlier
drafts. Peter Hawthorne helped with statistical analysis of the ADHD literature. The
Mark and Judy Yudof Fellowship, 2006-2007, and a Doctoral Dissertation Fellowship
from the University of Minnesota, 2007-2008, provided research support.
1 . Gender differences in diagnosis raise important questions, but those issues are
beyond the scope of this article.
2. I use the term "diagnosable" or "ADHD-diagnosable" for two reasons. First, I
want to avoid reifying ADHD. Second, some people who meet ADHD criteria are not
diagnosed, either by choice, or because they lack access to health care.
3. The term "value valence" avoids two connotations of the term "value laden":
that the values embedded are bad values, and that having values embedded is undesir-
able. In medicine and clinical science, neither is necessarily the case.
4. See Mayes et al. 2009 for the history of ADHD.
5. To quantify authors' views of ADHD etiology, I analyzed a random sample of
150 research articles on ADHD or ADD published between 1990 and 2009, inclusive,
and indexed in ERIC, PsychlNFO, or PubMed. If the article concerned drug interven-
tion, described etiology as "neuronal," or measured biological parameters (e.g.), this
suggested a primarily biological view (87/150); measurement of behavioral (7/150), psy-
chosocial (2/150), communication (2/150), educational (0/150), or other parameters
suggested emphasis on other views. Often, the view was ambiguous (28/150), or the
author specified a mixed understanding (15/150). (Nine articles were not available to
me online.) The biological majority is statistically significant by the Pearson j1 test.
Details available on request.
6. M. B. First and D. J. Kupfer favor categorical models, but they nicely summarize
arguments for dimensional criteria (First 2005; Kupfer 2005).
References
Abikoff, Howard B., and Lily Hechtman, et al. 2004. Social functioning in children
with ADHD treated with long-term methylphenidate and multimodal psychoso-
cial treatment. Journal of the American Academy of Child and Adolescent Psychiatry 43
(7): 820-9.
Adler, Lenard, Ronald C. Kessler, and Thomas Spencer, n.d. Adult ADHD self-report
scale symptom checklist, http://www.med.nyu.edu/psych/assets/adhdscreenl8.pdf
(accessed February 20, 2009).
American Academy ot Child and Adolescent Fsychiatry (AACAF). ZUUZ. AA<JA1J
official action: Practice parameter for the use of stimulant medications in the treat-
ment of children, adolescents, and adults. Journal of the American Academy of Child
and Adolescent Psychiatry 41(2, suppl.): 26S-49S.
http://www.aacap.org/cs/2007_press_releases/aacap
tice.parametei^and.pocketcard (accessed April 29
American Academy of Pediatrics: Subcommittee on A
Disorder: Committee on Quality Improvement. 200
Treatment of the school-aged child with attention-d
Pediatrics 108 (4): 1033-44.
American Psychiatric Association. 2000. Diagnostic and
orders. Text revision. 4th ed. Arlington, Va.: Ameri
Anderson, Elizabeth. 2004. Uses of value judgments
with lessons from a case study of feminist research
Angeli, Marcia. 2004. The truth about the drug companies
do about it. New York: Random House.
Arnold, L.E., and H.B. Abikoff, et al. 1997. National
laborative multimodal treatment study of child
Design challenges and choices. Archives of General P
Biederman, Joseph, and Stephen V. Faraone. 2005. Atte
order. Lancet 366 (9481): 237-48.